SanofiSNYNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank59
3Y CAGR-20.6%
5Y CAGR-24.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-20.6%/yr
Quarterly compound
5Y CAGR
-24.4%/yr
Recent acceleration
Percentile
P59
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.76% |
| Q3 2025 | -12.89% |
| Q2 2025 | 18.36% |
| Q1 2025 | 78.90% |
| Q4 2024 | -53.67% |
| Q3 2024 | 0.98% |
| Q2 2024 | 25.77% |
| Q1 2024 | -27.98% |
| Q4 2023 | 13.65% |
| Q3 2023 | 0.16% |
| Q2 2023 | -1.23% |
| Q1 2023 | -9.95% |
| Q4 2022 | 9.49% |
| Q3 2022 | 2.72% |
| Q2 2022 | 8.20% |
| Q1 2022 | -13.74% |
| Q4 2021 | 21.71% |
| Q3 2021 | -3.00% |
| Q2 2021 | 6.47% |
| Q1 2021 | -15.68% |
| Q4 2020 | 19.25% |
| Q3 2020 | -3.66% |
| Q2 2020 | -3.29% |
| Q1 2020 | -14.43% |
| Q4 2019 | 18.43% |
| Q3 2019 | -6.02% |
| Q2 2019 | 3.49% |
| Q1 2019 | -12.97% |
| Q4 2018 | 18.18% |
| Q3 2018 | -7.86% |
| Q2 2018 | 8.43% |
| Q1 2018 | -14.31% |
| Q4 2017 | 16.59% |
| Q3 2017 | -9.89% |
| Q2 2017 | 3.63% |
| Q1 2017 | -4.80% |
| Q4 2016 | 14.47% |
| Q3 2016 | -5.13% |
| Q2 2016 | 8.36% |
| Q1 2016 | 20.54% |